Detalhe da pesquisa
1.
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Kidney Int
; 93(1): 147-158, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843411
2.
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
Int J Mol Sci
; 19(9)2018 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142896
3.
Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
Kidney Int
; 91(1): 86-95, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27666759
4.
Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.
Kidney Int
; 89(6): 1231-43, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27165838
5.
Pathophysiology of the chronic kidney disease-mineral bone disorder.
Curr Opin Nephrol Hypertens
; 24(4): 303-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26050115
6.
CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.
J Am Soc Nephrol
; 25(8): 1760-73, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578135
7.
Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity.
J Cell Biochem
; 115(6): 1043-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24420069
8.
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
Kidney Int
; 85(1): 142-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23884339
9.
Connexin43 in mesenchymal lineage cells regulates body adiposity and energy metabolism in mice.
bioRxiv
; 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260624
10.
Connexin43 in mesenchymal lineage cells regulates body adiposity and energy metabolism in mice.
JCI Insight
; 9(6)2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349739
11.
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis.
J Cell Biochem
; 114(6): 1217-22, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23238785
12.
A microRNA expression signature of osteoclastogenesis.
Blood
; 117(13): 3648-57, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21273303
13.
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?
Kidney Int Suppl
; (121): S9-13, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21346719
14.
The mechanism of phosphorus as a cardiovascular risk factor in CKD.
J Am Soc Nephrol
; 19(6): 1092-105, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18417722
15.
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.
Bone
; 100: 80-86, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28119179
16.
SIRT6 deficiency culminates in low-turnover osteopenia.
Bone
; 81: 168-177, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26189760
17.
Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line.
Arch Oral Biol
; 48(1): 63-7, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12615143
18.
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?
Kidney Int
; 79121: S9-S13, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26746860
19.
Impaired micro-RNA pathways diminish osteoclast differentiation and function.
J Biol Chem
; 284(7): 4667-78, 2009 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19059913
20.
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors.
J Biol Chem
; 280(5): 3583-9, 2005 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15545269